UCB SA (UCBJY) Q2 2026 Earnings Call Transcript

UCB SA (UCBJY) Q2 2026 Earnings Call July 30, 2026 8:00 AM EDT

Yvonne Naughton Head of Investor Relations: A warm welcome to UCB's Half Year 2026 Presentation Conference Call and webcast for investors and analysts. I'm Yvonne Naughton, Head of Investor Relations. Before I hand over to Jean-Christophe and members of our executive team, I would like to cover some housekeeping items. Today's presentation is available for download on the Investor Relations section of our website. The presentation and Q&A session are subject to the disclaimer and safe harbor statement contained on Slide 2 of the presentation. Moving to Slide 3. Our speakers today are Jean-Christophe Tellier, Chief Executive Officer; Emmanuel Caeymaex, Executive Vice President and Head of Patient Evidence; Fiona du Monceau, Executive Vice President and Chief Commercial Officer; and Sandrine Dufour, Executive Vice President and Chief Financial Officer. Following our prepared remarks, we will open the line for questions. As usual, we will try to address as many questions as we can. So please limit your questions to allow others a fair chance to participate in the Q&A. And with that, I'll hand over to you Jean-Christophe.